SCHEMBL5344905

SCHEMBL5344905

COc1ccc(CNC(=O)[C@](N)(CS(=O)(=O)CC2CCCC2)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
KMT2A Q03164 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MMP1 P03956 1/20 0.43
MMP9 P14780 1/20 0.43
MMP13 P45452 1/20 0.43
ADAM17 P78536 1/20 0.43
SCN9A Q15858 1/20 0.43
TP53 P04637 1/20 0.40
LMNA P02545 1/20 0.40
CPB2 Q96IY4 1/20 0.40
MEN1 O00255 1/20 0.40
PKM P14618 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5350153 1.00 ALDH1A1 (0.45) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL5364198 0.99 ALDH1A1 (0.46) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL5351225 0.86 ALDH1A1 (0.48) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL5349845 0.86 ALDH1A1 (0.48) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL5355909 0.84 NPC1 (0.50) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL5755414 0.81 ALDH1A1 (0.47) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL5757246 0.81 ALDH1A1 (0.47) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL5348813 0.81 SMN1; SMN2 (0.46) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL5354048 0.81 ALDH1A1 (0.50) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL5350936 0.80 ALDH1A1 (0.46) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166590-B2 Amino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2007-01-23 US disclosed
US-20030013725-A1 Amino acid derivatives ONO PHARMACEUTICAL CO., LTD. 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013725-A1 Amino acid derivatives CACNA1B, SCN1A, SCN2A ALDH1A1 3065/4885KMT2A 1929/4885SMN1; SMN2 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.